PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Transfusion Medicine, Department of Pathology, University of Michigan, Ann Arbor, Michigan, USA.\', \'Division of Transfusion Medicine, Department of Laboratory Medicine, University of California San Francisco School of Medicine, San Francisco, California, USA.\', \'Division of Pediatric Apheresis, Department of Pediatrics, St. Anna Kinderspital, Medical University of Vienna, Vienna, Austria.\', \'Transfusion Medicine and Cell Therapy, Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.\', \'Division of Transfusion Medicine, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1002/jca.21939
?:doi
?:hasPublicationType
?:journal
  • Journal of clinical apheresis
is ?:pmid of
?:pmid
?:pmid
  • 34510542
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.825
?:rankingScore_hIndex
  • 40
?:title
  • The report from ASFA COVID-19 taskforce: Considerations and prioritization on apheresis procedures during the SARS-CoV-2 coronavirus disease (COVID-19) pandemic.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all